ID: ALA3407932

Max Phase: Preclinical

Molecular Formula: C21H13F3N2O3

Molecular Weight: 398.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Oc1ccc(-c2nc(-c3ccc(Oc4ccc(C(F)(F)F)cc4)cc3)no2)cc1

Standard InChI:  InChI=1S/C21H13F3N2O3/c22-21(23,24)15-5-11-18(12-6-15)28-17-9-3-13(4-10-17)19-25-20(29-26-19)14-1-7-16(27)8-2-14/h1-12,27H

Standard InChI Key:  VDOWOJJPGBRUSZ-UHFFFAOYSA-N

Associated Targets(Human)

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Enterococcus faecium 13803 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Enterococcus faecalis 29875 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bacillus licheniformis 140 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bacillus cereus 7522 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Streptococcus pyogenes 16140 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Streptococcus oralis 178 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus haemolyticus 1695 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus epidermidis 22802 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 398.34Molecular Weight (Monoisotopic): 398.0878AlogP: 5.92#Rotatable Bonds: 4
Polar Surface Area: 68.38Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.85CX Basic pKa: CX LogP: 6.25CX LogD: 6.24
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.46Np Likeness Score: -1.09

References

1. Spink E, Ding D, Peng Z, Boudreau MA, Leemans E, Lastochkin E, Song W, Lichtenwalter K, O'Daniel PI, Testero SA, Pi H, Schroeder VA, Wolter WR, Antunes NT, Suckow MA, Vakulenko S, Chang M, Mobashery S..  (2015)  Structure-activity relationship for the oxadiazole class of antibiotics.,  58  (3): [PMID:25590813] [10.1021/jm501661f]
2. Leemans E, Mahasenan KV, Kumarasiri M, Spink E, Ding D, O'Daniel PI, Boudreau MA, Lastochkin E, Testero SA, Yamaguchi T, Lee M, Hesek D, Fisher JF, Chang M, Mobashery S..  (2016)  Three-dimensional QSAR analysis and design of new 1,2,4-oxadiazole antibacterials.,  26  (3): [PMID:26733473] [10.1016/j.bmcl.2015.12.041]
3. Verma SK, Verma R, Kumar KSS, Banjare L, Shaik AB, Bhandare RR, Rakesh KP, Rangappa KS..  (2021)  A key review on oxadiazole analogs as potential methicillin-resistant Staphylococcus aureus (MRSA) activity: Structure-activity relationship studies.,  219  [PMID:33878562] [10.1016/j.ejmech.2021.113442]
4. Shalaby MW, Dokla EME, Serya RAT, Abouzid KAM..  (2020)  Penicillin binding protein 2a: An overview and a medicinal chemistry perspective.,  199  [PMID:32442851] [10.1016/j.ejmech.2020.112312]

Source